4//SEC Filing
KEEGAN JOSEPH D 4
Accession 0001493152-18-003191
CIK 0001054102other
Filed
Mar 8, 7:00 PM ET
Accepted
Mar 9, 5:31 PM ET
Size
7.7 KB
Accession
0001493152-18-003191
Insider Transaction Report
Form 4
KEEGAN JOSEPH D
Director
Transactions
- Award
Common Stock
2018-03-07+4,800→ 17,569 total - Award
Stock Option (right to buy)
2018-03-07+19,200→ 19,200 totalExercise: $1.01Exp: 2018-03-07→ Common Stock (19,200 underlying)
Footnotes (4)
- [F1]The restricted units vest annually, in equal installments, over a three-year period, commencing on March 7, 2019.
- [F2]Each restricted unit represents the contingent right to receive one share of common stock of Interpace Diagnostics Group, Inc. (the "Issuer").
- [F3]Reflects 1-for-10 reverse stock split, effective as of December 28, 2016.
- [F4]The option award vests and becomes exercisable over a three-year period, in equal installments, commencing on March 7, 2019, subject to the reporting person's continued service with the Issuer.
Documents
Issuer
Interpace Diagnostics Group, Inc.
CIK 0001054102
Entity typeother
Related Parties
1- filerCIK 0001260556
Filing Metadata
- Form type
- 4
- Filed
- Mar 8, 7:00 PM ET
- Accepted
- Mar 9, 5:31 PM ET
- Size
- 7.7 KB